OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
OncoAlert Colloquium Day 4: GI oncology and EONS
OncoAlert Colloquium Day 3: Breast cancer
OncoAlert Colloquium Day 2: Lung cancer and MASCC
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Social distancing and economic crisis in Latin America during the COVID-19 pandemic
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease
The RxPONDER trial and its impact on best clinical practice
WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine